Intracin Pharmaceuticals Private Limited, based in Nadiad, Gujarat, India, is a leading veterinary pharmaceutical company specializing in the development, manufacturing, and export of veterinary medicines. With a commitment to quality, efficacy, and compliance, Intracin serves clients across India and international markets, focusing on the well-being of livestock and companion animals.
Core Business
Intracin operates in the veterinary healthcare segment, manufacturing a broad range of pharmaceutical formulations, including injections, oral liquids, soluble powders, and feed supplements. The company addresses the critical need for reliable and affordable animal healthcare solutions, serving poultry, dairy, equine, and pet animal sectors.
Product and Service Offerings
Intracin's diversified product portfolio is categorized into the following segments:
-
Veterinary Injections:
- Buparvaquone Injection: Used for treating tropical theileriosis in cattle.
- Meloxicam and Paracetamol Injection: NSAID combination for anti-inflammatory and analgesic purposes.
- Oxytetracycline Injection: Broad-spectrum antibiotic for bacterial infections.
-
Medicinal Water Soluble Powders:
- Levamisole Hydrochloride Powder: Anthelmintic treatment for internal parasitic infections.
- Doxycycline Hyclate Powder: Antibiotic for respiratory and intestinal infections in poultry and livestock.
-
Nutritional Oral Liquids:
- Vitamin B12 Oral Solution: Supports hematinic functions and general health.
- Liver Tonic: Improves liver metabolism and enhances feed conversion ratio.
Specialization and Core USP
Intracin's core strength lies in its ability to deliver high-quality veterinary formulations at competitive prices while maintaining stringent regulatory compliance. Key unique selling points include:
- End-to-End Manufacturing: Fully integrated facility for formulation, filling, and packaging.
- Product Stability and Shelf Life: Formulations optimized for tropical climates and global distribution.
- Customized Formulation Services: Capability to develop client-specific compositions and branding.
Financials
Intracin Pharmaceuticals is a private entity, and while detailed financial data is not publicly disclosed, key financial indicators based on market intelligence suggest:
- Annual Revenue Estimate (2022–23): ₹20–25 Crores (approx. $2.5–3.1 million USD)
- Export Contribution: Estimated 60–70% of total sales through partnerships in Africa, Southeast Asia, and the Middle East.
Shipments and Global Reach
- Export Markets: Strong footprint in countries like Kenya, Nigeria, Bangladesh, Nepal, and Myanmar.
- Export Categories: Primarily veterinary injectables and soluble powders for livestock.
- Volume and Frequency: Regular shipments facilitated through partnerships with global distributors and tender-based supply chains.
Target Market
Intracin's primary clientele includes:
- Veterinary Hospitals and Clinics
- Livestock Farms and Cooperatives
- Poultry Integrators
- Pharmaceutical Distributors
- Government and NGO Animal Health Programs
The company caters to both B2B and institutional buyers, particularly in emerging markets with a high demand for cost-effective veterinary care.
Capabilities
Intracin’s technical and operational capabilities comprise:
- WHO-GMP Certified Manufacturing Facility
- Dedicated Quality Control and Microbiology Labs
- R&D Department for New Formulation Development
- Private Label and Contract Manufacturing Capabilities
- Regulatory Dossier Preparation for International Markets
Certifications and Compliance
The company adheres to stringent quality and regulatory standards to ensure market eligibility:
- WHO-GMP Certification for Good Manufacturing Practices
- FSSAI Approval for nutritional and feed products
- Drug License Compliance under Indian Drug & Cosmetics Act
- Ongoing Accreditation Pursuits for international GMP recognition in ASEAN and African regions
Customer Testimonials
Public testimonials are limited, but long-standing partnerships with veterinary distributors and consistent repeat orders highlight high customer satisfaction. Many clients recognize the brand for its consistency in quality and competitive pricing.
Major Achievements
- Export Expansion to 15+ Countries within the last five years.
- Diversification into Multimodal Formulations including injectables, orals, and nutraceuticals.
- Achievement of WHO-GMP Certification enhancing global compliance and regulatory acceptance.
- Introduction of Antibiotic Alternatives and Nutritional Supplements tailored to the growing demand for residue-free animal products.
Intracin Pharmaceuticals continues to build its reputation as a reliable partner for veterinary healthcare, driven by innovation, integrity, and a focus on animal welfare in both domestic and international markets.
